Condition
Cholangiocarcinoma Non-resectable clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cholangiocarcinoma Non-resectable clinical trials that are recruiting, at sites in 4 countries (most in China (2), France (1), Norway (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Cholangiocarcinoma Non-resectable clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Preoperative Right Hepatic Artery Embolization to enable surgery for advanced perihilar cholangiocarcinoma | — | Guangzhou, Guangdong | Recruiting | Jan 8, 2026 |
| Investigating liver and pancreas surgery followed by transplantation for advanced cholangiocarcinoma | — | Oslo | Recruiting | Feb 27, 2025 |
| Combination therapy for patients with unresectable intrahepatic cholangiocarcinoma | Phase 2 | Wuhan, Hubei | Recruiting | Jan 5, 2024 |
| Combination treatment for advanced bile duct cancer | Phase 2 | Boston, Massachusetts | Recruiting | Dec 19, 2022 |
| Hepatic arterial infusion of gemcitabine and oxaliplatin for treating non-resectable intra-hepatic cholangiocarcinoma | Phase 2 | Amiens and 6 other locations | Recruiting | Dec 6, 2017 |
All recruiting trials (5)
-
Preoperative Right Hepatic Artery Embolization to enable surgery for advanced perihilar cholangiocarcinoma
A single-arm study tests whether embolizing the right hepatic artery before surgery helps patients with unresectable, locally advanced perihilar cholangiocarcinoma become eligible for radical liver surgery.
-
Investigating liver and pancreas surgery followed by transplantation for advanced cholangiocarcinoma
This study is testing a new surgery method for patients with advanced bile duct cancer to see if removing the liver and pancreas together, followed by a liver transplant, can help them live longer.
-
Combination therapy for patients with unresectable intrahepatic cholangiocarcinoma
This study is testing a new combination of chemotherapy and targeted therapy to see if it can shrink tumors in patients with a type of liver cancer that can't be surgically removed.
-
Combination treatment for advanced bile duct cancer
This study is testing a new combination treatment for patients with advanced bile duct cancer that can't be surgically removed to see if it helps them feel better and live longer.
-
Hepatic arterial infusion of gemcitabine and oxaliplatin for treating non-resectable intra-hepatic cholangiocarcinoma
This study is testing a new way to deliver two cancer drugs directly to the liver to see if it helps patients with a specific type of liver cancer that can't be surgically removed.
Related topics
Quick answers
How many Cholangiocarcinoma Non-resectable clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), France (1 trial), Norway (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.